PV is characterised by the presence of a Janus kinase 2 (JAK2) mutation, erythrocytosis, and panmyelosis on bone marrow biopsy and is associated with an increased risk of thrombosis based on age and other risk factors. Here, JAK2 is linked to acquired polycythemia vera.